Displaying 1 - 10 of 11 for Eye and Vision
  • Artificial Iris Study (H-33025)
    • The purpose of this study is to evaluate the safety and effectiveness of an artificial iris prosthesis for the treatment of iris defects.
  • Cataract Surgery Postop Inflammation and Pain (H-39061)
    • The primary objective of this study is to evaluate the safety and efficacy of loteprednol etabonate ophthalmic gel, 0.38% (BID and TID) for the treatment of postoperative inflammation and pain following cataract surgery.
  • Corneal Cross-Linking Study (H-35038)
    • This is a study of the safety and effectiveness of collagen cross-linking in eyes with keratoconus or ectasia.
  • Corneal Epithelial Disorders Study (H-39653)
    • The purpose of this study is to investigate the safety and efficacy of two different doses of SJP-0035 ophthalmic solution in patients with corneal epithelial disorders.
  • Diabetic Retinopathy Study (H-38338)
    • The purpose of this study is to determine the efficacy and safety of intravitreous aflibercept injections versus sham injections (observation) for prevention of PDR or CI-DME in eyes at high risk for development of these complications.
  • Dry Eye Disease Study (H-39292)
    • The purpose of this study is to evaluate the effect of treatment with 0.017% P-321 on dry eye symptoms.
  • Glaucoma Study (H-35589)
    • The purpose of this study is to investigate the efficacy and safety of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension.
  • Ocular Surface Study (Dry Eye) (H-36270)
    • The primary objective of this study is to evaluate the efficacy of 20 µg/ml six times a day of rhNGF eye drops solution (formulation containing anti-oxidant) compared to vehicle (formulation containing anti-oxidant) given six times a day.
  • Retina Study (H-36501)
    • The purpose of this study is to see how safe and effective an investigational drug, RTH258, is in people who have age-related macular degeneration (AMD).
  • Stargardt Macular Degeneration Study (H-37011)
    • A study drug is being tested to see if it can successfully transfer a normal copy of the ABCA4 gene into the eye of the person with SMD.